Program Guidelines for the National Lung Cancer Screening Program: Targeted Lung Cancer Screening in… | ScholarDeck

Paper

Program Guidelines for the National Lung Cancer Screening Program: Targeted Lung Cancer Screening in High-Risk Individuals in Australia.

New research · Internal Medicine

The Medical journal of Australia · 1mo

GuidelineThe Medical journal of Australia· Jul 2026

Program Guidelines for the National Lung Cancer Screening Program: Targeted Lung Cancer Screening in High-Risk Individuals in Australia.

Nicole M Rankin, Rebecca Zosel, Lisa J Whop … Vivienne Milch

Read paper

OncologyGuidelineClinical practiceQ1IF 2.9

Australian lung cancer screening targets individuals aged 50 to 70 years.

Program Guidelines for the National Lung Cancer Screening Program: Targeted Lung Cancer Screening in High-Risk Individuals in Australia.

Nicole M Rankin … Vivienne Milch

The Medical journal of Australia · Jul 2026 · Q1 in General Medicine

Background

Lung cancer is the leading cause of cancer mortality in Australia.

Purpose

The purpose of the guidelines is to ensure safe, effective and high-quality Program delivery, detailing key steps for clinical practice and information for participating healthcare providers.

Results

and 70 years of age

Australians within this age range are eligible for lung cancer screening

More results

This guideline provides recommendations for the delivery of targeted low-dose CT screening for lung cancer in the Australian context.

“

Conclusion

The full guideline is available at https://www.health.gov.au/resources/publications/nlcsp-guidelines.

Read paper

0 comments

No comments yet. Be the first.

ScholarDeck.

Join the discussion on this paper

Create your profile

Related papers

Latest Foundational

Cohort Study

SIR 6.55

over sixfold higher risk of oral and pharyngeal cancer than the general population

Systematic Review

19.6%

About 1 in 5 patients tested with next-generation sequencing received a confirmed diagnosis.

Cohort Study

OR = 0.161

lower IgM independently predicted gastrointestinal involvement

Cross-sectional

κ=0.324

Kappa of 0.324 (1.0=perfect) shows modest but statistically significant agreement between the two liver tests

Cohort Study

AUC 0.80

higher scores mean more accurate at flagging this condition

Cohort Study

21.4%

1 in 5 immunodeficient rheumatoid arthritis patients carry a likely disease-causing immune gene variant

Case Report

1 year

still in remission a year after transplant, a promising sign of cure

Cohort Study

96.42%

nearly all children survived and stayed engrafted at 2 years